A detailed history of Torno Capital, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Torno Capital, LLC holds 7,000 shares of PCVX stock, worth $520,590. This represents 0.05% of its overall portfolio holdings.

Number of Shares
7,000
Previous 57,000 87.72%
Holding current value
$520,590
Previous $6.51 Billion 91.2%
% of portfolio
0.05%
Previous 1.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$80.97 - $117.93 $161,940 - $235,860
-2,000 Reduced 22.22%
7,000 $573 Million
Q3 2024

Nov 13, 2024

BUY
$70.52 - $117.12 $634,680 - $1.05 Million
9,000 New
9,000 $1.03 Billion

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $4.41B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Torno Capital, LLC Portfolio

Follow Torno Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Torno Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Torno Capital, LLC with notifications on news.